NegativeClinical Trial2022
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
Classification Results
AI Classification
NegativeFine-tuned Classification
N/A